Daniel M. Bendheim, Executive VP, Corporate Strategy at PHIBRO ANIMAL HEALTH CORP (PAHC), sold 7,500 shares at $31.72 ($238K) on 2019-01-03, disclosed to the SEC on 2019-01-07.
Open-market sale of $238k PAHC by Executive VP, Corporate Strategy. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.72 | 2,500 | $79K | 33.3% |
| 2 | $31.30 | 2,500 | $78K | 32.9% |
| 3 | $32.21 | 2,500 | $81K | 33.8% |
| Total | $31.74 avg | 7,500 | $238K | 100% |
| Filing → |
| PAHC | SELL | 2019-01-18 | $242K | — | Filing → |
| PAHC | SELL | 2019-01-10 | $162K | — | Filing → |
| PAHC | SELL | 2018-09-14 | $111K | — | Filing → |